Patent · US Active

Polylysine dendrimer contrast agent

US9127130B2 · kind B2 · utility

1Cited by

2References

30Claims

0Family size

Assignees

Starpharma Pty Ltd. · AU
BAKER IDI HEART AND DIABETES INSTITUT HOLDINGS LTD. · AU

Inventors

Guy Krippner · Melbourne, AU
Zemin Wu · Melbourne, AU
Karlheinz Peter · Molfsee, DE
Christoph Hagemeyer · Melbourne, AU
David Owen · Melbourne, AU

Key dates

Filing date	Aug 10, 2007
Grant date	Sep 8, 2015
Priority date	—
Expiry date	Jul 2, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08L77/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates generally to branched macromolecules and their use as imaging or contrast agents. In particular, the invention relates to dendrimers, derived from lysine or lysine analogs, bearing a plurality of functional moieties and their application to imaging techniques in which a disease state may be imaged with a targeted contrast agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.